. Author manuscript; available in PMC: 2018 Apr 6.

Published in final edited form as: Int Arch Allergy Immunol. 2017 Apr 6;172(3):139–149. doi: 10.1159/000455254

Table 2.

G. applanatum crude spore cytoplasmic extract (CSCE) indirect ELISA sample groups

Serum Samples with Different Allergic Profiles	Origin	Number
Group 1^†: Individuals^* with sIgE reactive to one or more allergens of the RAST allergens tested	Donated sera remnants from Toledo Clinical Laboratory, Arecibo, PR	51
Group 2^†: Individuals^* with no reactive sIgE to the RAST allergens tested	Donated sera remnants from Toledo Clinical Laboratory, Arecibo, PR	14
Group 3^††: Individuals^* with no previous history of allergic disease based on self-reported symptomatology	Puerto Rican adult volunteers from the UPR-MSC community	22
Total		87

^†

Individuals in these groups were suspected of having allergic symptomatology due to the medical referral for sIgE testing. The serum samples were not tested to the same battery of commercial allergens.

^††

This group is not considered a negative control group because no skin or serological tests were performed to confirm absence of allergic sensitization.

Clinical history of individuals is unknown.